Clinical trial
Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer
NCT00079300 · National Naval Medical Center, U.S. Fed · Completed
Key facts
| NCT number | NCT00079300 |
|---|---|
| Title | Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer |
| Official title | Double-Blind, Vehicle-Controlled Study to Evaluate Apoptosis in Basal Cell Carcinoma Treated With Aldara™ (Imiquimod) Cream, 5% Applied Once or Twice a Day |
| Lead sponsor | National Naval Medical Center, U.S. Fed |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Non-melanomatous Skin Cancer |
| Intervention type | Drug, Procedure |
| Interventions | imiquimod, conventional surgery |
| Start date | Jan 1, 2004 |
| Completion | Aug 1, 2005 |
| First posted | Mar 10, 2004 |
| Last update posted | Apr 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: